多发性硬化神经保护与修复的影像学结局指标:NAIMS共识声明
北美多发性硬化影像学合作组织(NAIMS)于2016年在加拿大多伦多召开专家研讨会,汇总当前与新兴的MRI技术,并就各技术在临床试验中评估多发性硬化神经保护与修复的潜在用途形成共识意见。共识指出,神经保护与修复的影像生物标志物仍是多发性硬化未满足的需求,多种技术各有优势与局限,具体技术选择取决于试验所要回答的问题。
要点
- 神经保护与修复的影像生物标志物在多发性硬化中属未满足需求。
- 共识覆盖常规MRI、MTI、DTI、SWI、磁共振波谱、PET等多种技术。
- 影像技术选择应依据临床试验所希望回答的具体问题。
核心结论
- 神经保护与修复的影像生物标志物是多发性硬化未满足的需求。
- 现有多种有前景的技术,各有不同优势与局限。
- 特定技术的选择取决于多种因素,尤其是试验所要回答的问题。
- 持续的合作努力将进一步完善和改进对神经保护与修复类治疗药物效果的成像方法。
研究设计与样本
- 讨论内容整理成稿件后在全体出席的NAIMS成员中传阅,纳入修改与反馈直至所有作者达成一致。
主要发现
- 在特定研究设计背景下讨论了广泛的影像技术与分析方法,重点是各技术用于评估神经保护与修复的效用与局限。
- 讨论按特定主题展开,包括常规成像、磁化传递率、弥散张量成像、磁敏感加权成像、皮层病灶成像、磁共振波谱、PET、高级弥散成像、钠成像、多模态技术、特殊区域成像、统计学考量与研究设计。
临床怎么用
- 在开展多发性硬化神经保护与修复相关临床试验时,可依据试验目的从共识列出的影像技术中选择合适的结局指标。
- 应用时应充分权衡各成像技术的优势与局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To summarize current and emerging imaging techniques that can be used to assess neuroprotection and repair in multiple sclerosis (MS), and to provide a consensus opinion on the potential utility of each technique in clinical trial settings. METHODS: Clinicians and scientists with expertise in the use of MRI in MS convened in Toronto, Canada, in November 2016 at a North American Imaging in Multiple Sclerosis (NAIMS) Cooperative workshop meeting. The discussion was compiled into a manuscript and circulated to all NAIMS members in attendance. Edits and feedback were incorporated until all authors were in agreement. RESULTS: A wide spectrum of imaging techniques and analysis methods in the context of specific study designs were discussed, with a focus on the utility and limitations of applying each technique to assess neuroprotection and repair. Techniques were discussed under specific themes, and included conventional imaging, magnetization transfer ratio, diffusion tensor imaging, susceptibility-weighted imaging, imaging cortical lesions, magnetic resonance spectroscopy, PET, advanced diffusion imaging, sodium imaging, multimodal techniques, imaging of special regions, statistical considerations, and study design. CONCLUSIONS: Imaging biomarkers of neuroprotection and repair are an unmet need in MS. There are a number of promising techniques with different strengths and limitations, and selection of a specific technique will depend on a number of factors, notably the question the trial seeks to answer. Ongoing collaborative efforts will enable further refinement and improved methods to image the effect of novel therapeutic agents that exert benefit in MS predominately through neuroprotective and reparative mechanisms.
引用
- Oh J, Ontaneda D, Azevedo C, et al. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS. Neurology. 2019. PMID: 30787160. doi:10.1212/WNL.0000000000007099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。